Abbott's board announced a quarterly dividend of 63 cents per share, payable on November 16, 2026, to shareholders recorded by October 15, 2026. This marks Abbott's 411th consecutive quarterly dividend since 1924 and continues its streak of 54 years of annual dividend increases. Abbott is recognized as a Dividend Aristocrat, reflecting its strong commitment to returning value to shareholders. The company remains a global leader in healthcare with a diverse portfolio serving over 160 countries.
Abbott Laboratories trades at USD 101.45 on Pluang as of September 17, 2026, with a dividend yield of 2.46%. The stock has seen a slight 0.89% decline in the last day and is currently experiencing predominantly sell orders at 97%. This dividend announcement adds to Abbott's long-standing reputation, which is reflected in its stable market presence and investor activity on Pluang.
Abbott announced results from the Beta-CORRECT study showing its Oncodetect test, using whole-genome sequencing, improves detection of molecular residual disease (MRD) in colorectal cancer patients after surgery. The test showed a 30% higher sensitiv...
Abbott Laboratories announced plans to spin off its Nutrition division to concentrate on higher-growth areas like diagnostics, medical devices, and pharmaceuticals. The company reported a 14.5% increase in Q3 revenue to $13.01 billion, driven mainly ...
Abbott Laboratories reported Q3 2026 results with adjusted earnings per share of $1.42, matching estimates, and revenue of $13.01 billion, slightly above expectations. Despite 14.5% sales growth, the company lowered its 2026 sales growth forecast due...
Abbott posted a 14.5% increase in reported sales and 7.0% comparable sales growth for Q3 2026, with GAAP diluted EPS of $0.53 and adjusted EPS of $1.42. The company expanded its portfolio with FDA approvals for innovative products like the Libre Duo ...
Abbott announced plans to separate its Nutrition business into a standalone, publicly traded company by the end of 2027. The new Nutrition company will focus on the growing healthy nutrition market with $8.5 billion in annual sales and iconic brands ...
